Pharma TARP: A Troubled Asset Relief Program for Novel, Abandoned Projects in the Pharmaceutical Industry
Within days of each other, Pfizer, Merck, and GlaxoSmithKline announced that they will focus on a few therapeutic areas only and abandon others entirely. Pfizer alone will close well over a hundred drug development projects that have reached two-thirds of the way to launch. The programs are deemed t...
Saved in:
Main Authors: | Tamas Bartfai, Graham Vaughan Lees |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2011.61 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE IDENTIFICATION AND SYSTEMATIZATION OF FINANCIAL ASSETS AND LIABILITIES, EXPOSED TO FINANCIAL RISKS, ON THE EXAMPLE OF THE PHARMACEUTICAL INDUSTRY
by: O. Ageeva, et al.
Published: (2019-06-01) -
Emerging Trends in Bioavailability and Pharma-Nutraceutical Potential of Whey Bioactives
by: Adhithyan T. Pillai, et al.
Published: (2024-01-01) -
TRANSCENDENTALINIS EMPIRIZMAS: TARP HUSSERLIO IR DERRIDA
by: Natalie Depraz
Published: (2003-01-01) -
Big Pharma, Big Bucks, and a Big Pile o’ Pigs
Published: (2001-01-01) -
Darnus tekstilės gaminių vartojimas tarp Lietuvos jaunimo
by: Rasa Bartkutė, et al.
Published: (2024-05-01)